Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will host a conference call on November 10, 2021, at 4:30 p.m. ET to discuss its third quarter 2021 financial results. The call will provide an update on the company's business and can be accessed via its website's investor section. Schrödinger specializes in a physics-based software platform aimed at revolutionizing therapeutic and material discovery, offering faster and cost-effective solutions for its clients in multiple sectors.

Positive

• Schrödinger's software platform enables rapid discovery of high-quality molecules, enhancing drug development efficiency.
• The company collaborates with biopharmaceutical and industrial firms, indicating strong industry relationships.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a conference call and webcast on Wednesday, November 10, 2021, at 4:30 p.m. ET to discuss third quarter 2021 financial results and provide an update on its business.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To participate in the live call, please dial (833) 727-9520 (domestic) or +1 (830) 213-7697 (international) and refer to conference ID 2484045. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211029005050/en/

Jaren Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Source: Schrödinger

FAQ

When will Schrödinger announce its Q3 2021 financial results?

Schrödinger will announce its Q3 2021 financial results on November 10, 2021.

What is the purpose of Schrödinger's upcoming conference call?

The conference call will discuss the third quarter 2021 financial results and provide updates on the company's business.

How can I access the Schrödinger conference call?

The conference call can be accessed via Schrödinger’s website under 'News & Events' in the investors section.

What is Schrödinger's stock symbol?

Schrödinger's stock symbol is SDGR.

What does Schrödinger specialize in?

Schrödinger specializes in a physics-based software platform for drug discovery and materials applications.